Clinical Trials in Phoenix

Showing 2281-2300 of 7,960 trials

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

NCT03858634

Participants with diseases characterized by chronic pruritus experiencing moderate to severe pruritus will be enrolled in this pilot Phase 2 study. The diseases characterized by chronic pruritus investigated in this pilot study currently include chronic idiopathic urticaria (CIU), chronic idiopathic pruritus (CIP), lichen planus (LP), lichen simplex chronicus (LSC) and plaque psoriasis (PPs).

Chronic Idiopathic UrticariaChronic Idiopathic PruritusLichen Planus+2 more

Genentech, Inc.58 participantsStarted May 2019

Anniston, Alabama, United States • Phoenix, Arizona, United States • Hot Springs, Arkansas, United States +11 more locations

COMPLETED< 1 mile

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

NCT03718546

To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Quality of Life

Center for International Blood and Marrow Transplant Research754 participantsStarted Apr 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Duarte, California, United States +28 more locations

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Find Trials by Condition in Phoenix

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

Extension Study for 43USSA1705

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

A Study of LY3561774 in Participants With Mixed Dyslipidemia

SNV1521 in Participants with Advanced Solid Tumors

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Infant Mortality Reduction by the Mass Administration of Azithromycin

Brain Injury Rehabilitation Improving the Transition Experience